Skip to main content
Livermore
Livermore
ZHEN

Ilex Capital Partners (UK) LLP

SEC CIK
0001985486
Latest filing
Aug 14, 2026

The latest 13F from Ilex Capital Partners (UK) LLP covers Q2 2026 (filed Aug 14, 2026): 147 long positions worth $4.88B. The top 10 holdings make up 42.5% of the portfolio, and the largest is Procter & Gamble Co (PG) at 11.2%. Livermore has 11 filings on Form 13F from this institution, going back to Q4 2023.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
113
Est. +$2.36B
Added
17
Est. +$847.8M
Reduced
13
Est. −$624.3M
Sold out
43
Est. −$1.92B

Top 5 holdings

Share of this quarter's portfolio value

  1. PGProcter & Gamble Co
    11.2%$547.7MHistory
  2. FLUTFlutter Entertainment plc
    5.7%$279.1MHistory
  3. MDLZMondelez International, Inc.
    3.6%$176.4MHistory
  4. KDPKeurig Dr Pepper Inc.
    3.3%$162.7MHistory
  5. YUMYum Brands Inc
    3.3%$162.4MHistory

Share of portfolio

Top 5 holdings and the other 142 positions, by share of portfolio value

  1. PG11.2%
  2. FLUT5.7%
  3. MDLZ3.6%
  4. KDP3.3%
  5. YUM3.3%
  6. Other 142 positions72.8%

Biggest buys

New and added positions, by estimated amount bought

  1. PGProcter & Gamble Co
    +$340.2MAddedHistory
  2. FLUTFlutter Entertainment plc
    +$279.1MNewHistory
  3. MDLZMondelez International, Inc.
    +$176.4MNewHistory
  4. KDPKeurig Dr Pepper Inc.
    +$162.7MNewHistory
  5. YUMYum Brands Inc
    +$162.4MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. PGProcter & Gamble Co
    +6.19 pp5.0% → 11.2%History
  2. FLUTFlutter Entertainment plc
    +5.72 pp0.0% → 5.7%History
  3. MDLZMondelez International, Inc.
    +3.62 pp0.0% → 3.6%History
  4. KDPKeurig Dr Pepper Inc.
    +3.34 pp0.0% → 3.3%History
  5. YUMYum Brands Inc
    +3.33 pp0.0% → 3.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. PEPPepsiCo Inc
    −$246.6MSold outHistory
  2. MCDMcDonalds Corp
    −$187.0MSold outHistory
  3. MNSTMonster Beverage Corp
    −$177.7MReducedHistory
  4. BSXBoston Scientific Corp
    −$140.2MSold outHistory
  5. AAgilent Technologies, Inc.
    −$137.5MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. PEPPepsiCo Inc
    −6.08 pp6.1% → 0.0%History
  2. MCDMcDonalds Corp
    −4.61 pp4.6% → 0.0%History
  3. BSXBoston Scientific Corp
    −3.45 pp3.5% → 0.0%History
  4. AAgilent Technologies, Inc.
    −3.39 pp3.4% → 0.0%History
  5. RACEFerrari N.V.
    −3.34 pp3.3% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$4.88B
+$819.4M (+20.2%) vs. prior quarter
Positions
147
+70 vs. prior quarter
Top 10 concentration
42.5%
Top 10 as share of value
Turnover
56.9%
Q2 2026, one quarter
Average holding period
2.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2023), so positions held before then are understated.

13F filings by quarter

11 quarters, going back to Q4 2023. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $4.88B (Q2 2026)

Q4 2023: $715.8MQ1 2024: $1.02BQ2 2024: $975.9MQ3 2024: $1.48BQ4 2024: $1.56BQ1 2025: $2.45BQ2 2025: $3.02BQ3 2025: $3.13BQ4 2025: $3.54BQ1 2026: $4.06BQ2 2026: $4.88B
Q4 2023Q2 2026
13F filings of Ilex Capital Partners (UK) LLP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 2026147$4.88BPGFLUTMDLZvs. Q1 2026SEC
Q1 2026May 15, 202677$4.06BPEPONONPGvs. Q4 2025SEC
Q4 2025Feb 17, 202666$3.54BFLUTGISMKCvs. Q3 2025SEC
Q3 2025Nov 14, 2025135$3.13BGISRACEPGvs. Q2 2025SEC
Q2 2025Aug 14, 2025156$3.02BIFFSJMFLUTvs. Q1 2025SEC
Q1 2025May 15, 2025189$2.45BSJMMNSTKOvs. Q4 2024SEC
Q4 2024Feb 14, 202531$1.56BKMBCAGKOvs. Q3 2024SEC
Q3 2024Nov 14, 202425$1.48BMDLZKALCvs. Q2 2024SEC
Q2 2024Aug 14, 202420$975.9MKOKDPTMOvs. Q1 2024SEC
Q1 2024May 15, 202419$1.02BPGKOKHCvs. Q4 2023SEC
Q4 2023Feb 14, 202416$715.8MCLKHCCLX–SEC

13D and 13G filings

Companies where Ilex Capital Partners (UK) LLP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Ilex Capital Partners (UK) LLP does not currently report owning 5% or more of any company.

Latest filings

2 filings on file made by Ilex Capital Partners (UK) LLP or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Ilex Capital Partners (UK) LLP
CompanyFiled (ET)FormStakeChangeEvent dateFiling
GOOSCanada Goose Holdings Inc.May 14, 20269:45 AM ET13G4.10%1.87M shares−1.30 ppfrom 5.40%Below 5%Mar 31, 2026SEC
GOOSCanada Goose Holdings Inc.Feb 11, 20268:50 AM ET13G5.40%2.50M sharesNewDec 31, 2025SEC